Finance

Lists
1ZTS:BIT
Zoetis Inc
€66.60
+1.93%
(+1.26) 1D
Aug 21, 5:35:12 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1ZTS...
Open
€65.02
High
€67.00
Low
€64.84
Mkt. cap
32.12B
Avg. vol.
297.00
Volume
242.00
52-wk high
€138.70
52-wk low
€61.40
No. of employees
14K
Open
€65.02
High
€67.00
Low
€64.84
Mkt. cap
32.12B
Avg. vol.
297.00
Volume
242.00
52-wk high
€138.70
52-wk low
€61.40
No. of employees
14K
News stories
From web sources and news partners
Profile
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorPharmaceutical industry
Websitezoetis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.40B
2.39B
2.26B
2.47B
Cost of goods sold
682.00M
711.00M
640.00M
670.00M
Cost of revenue
682.00M
711.00M
640.00M
670.00M
Research and development expenses
170.00M
199.00M
180.00M
173.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
572.00M
618.00M
584.00M
589.00M
Operating expense
774.00M
848.00M
795.00M
793.00M
Total operating expenses
1.46B
1.56B
1.44B
1.46B
Operating income
944.00M
828.00M
827.00M
1.00B
Other non operating income
-
-6.00M
-1.00M
-2.00M
EBT including unusual items
887.00M
761.00M
758.00M
866.00M
EBT excluding unusual items
899.00M
780.00M
779.00M
948.00M
Income tax expense
166.00M
158.00M
157.00M
175.00M
Effective tax rate
18.71%
20.76%
20.71%
20.21%
Other operating expenses
-
-
-
-
Net income
721.00M
603.00M
601.00M
691.00M
Net profit margin
30.04%
25.26%
26.57%
28.00%
Earnings per share
1.70
1.48
1.53
1.87
Interest and investment income
26.00M
25.00M
21.00M
16.00M
Interest expense
-58.00M
-57.00M
-62.00M
-61.00M
Net interest expenses
-32.00M
-32.00M
-41.00M
-45.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.07B
903.00M
946.00M
1.12B
Gain or loss from assets sale
-
-
-6.00M
-1.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps